Cargando…

In Vitro and In Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2

Protein kinase CK2 is an emerging target for therapeutic intervention in human diseases, particularly in cancer. Inhibitors of this enzyme are currently in clinical trials, indicating the druggability of human CK2. By virtual screening of the ZINC database, we found that the natural compound bikaver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haidar, Samer, Aichele, Dagmar, Birus, Robin, Hielscher, Janine, Laitinen, Tuomo, Poso, Antti, Jose, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479664/ https://www.ncbi.nlm.nih.gov/pubmed/30965682 http://dx.doi.org/10.3390/molecules24071380

Ejemplares similares

Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining
por: Haidar, Samer, et al.
Publicado: (2017)

Natural Compounds Isolated from Stachybotrys chartarum Are Potent Inhibitors of Human Protein Kinase CK2
por: Haidar, Samer, et al.
Publicado: (2021)

Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α′
por: Hochscherf, Jennifer, et al.
Publicado: (2017)

Broad-Spectrum Anticancer Activity and Pharmacokinetic Properties of a Prenyloxy-Substituted Indeno[1,2-b]indole Derivative, Discovered as CK2 Inhibitor
por: El-Awaad, Ehab, et al.
Publicado: (2021)

4,5,7‐Trisubstituted indeno[1,2‐b]indole inhibits CK2 activity in tumor cells equivalent to CX‐4945 and shows strong anti‐migratory effects
por: Birus, Robin, et al.
Publicado: (2021)

QSAR Model of Indeno[1,2-b]indole Derivatives and Identification of N-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-b]furan-3-carboxamide as a Potent CK2 Inhibitor
por: Haidar, Samer, et al.
Publicado: (2019)

Pathway engineering in yeast for synthesizing the complex polyketide bikaverin
por: Zhao, Meng, et al.
Publicado: (2020)

Production of bikaverin by a Fusarium fujikuroi mutant in submerged cultures
por: Lale, G. J., et al.
Publicado: (2016)

Recovery and purification of bikaverin produced by Fusarium oxysporum CCT7620
por: Mendonça, Mayra, et al.
Publicado: (2021)

Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors
por: Zięba, Agata, et al.
Publicado: (2021)

Structural Characterization of LsrK as a Quorum Sensing Target and a Comparison between X-ray and Homology Models
por: Medarametla, Prasanthi, et al.
Publicado: (2021)

In Vitro Identification and In Vivo Confirmation of Inhibitors for Sweet Potato Chlorotic Stunt Virus RNA Silencing Suppressor, a Viral RNase III
por: Wang, Linping, et al.
Publicado: (2021)

Identification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library Screening
por: Nienberg, Christian, et al.
Publicado: (2017)

Benzimidazole inhibitors of protein kinase CK2 potently inhibit the activity of atypical protein kinase Rio1
por: Kubiński, Konrad, et al.
Publicado: (2016)

Assessment of mutation probabilities of KRAS G12 missense mutants and their long-timescale dynamics by atomistic molecular simulations and Markov state modeling
por: Pantsar, Tatu, et al.
Publicado: (2018)

A Functional Bikaverin Biosynthesis Gene Cluster in Rare Strains of Botrytis cinerea Is Positively Controlled by VELVET
por: Schumacher, Julia, et al.
Publicado: (2013)

Putative metabolic pathway for the bioproduction of bikaverin and intermediates thereof in the wild Fusarium oxysporum LCP531 strain
por: Lebeau, Juliana, et al.
Publicado: (2019)

Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid Tumors
por: Kalogirou, Andreas S., et al.
Publicado: (2021)

Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors
por: Kaczor, Agnieszka A., et al.
Publicado: (2015)

A π-Halogen Bond of Dibenzofuranones with the Gatekeeper Phe113 in Human Protein Kinase CK2 Leads to Potent Tight Binding Inhibitors
por: Schnitzler, Alexander, et al.
Publicado: (2018)

Identification of Ellagic acid analogues as potent inhibitor of protein Kinase CK2:A chemopreventive role in oral Cancer
por: Srivastava, Rashi, et al.
Publicado: (2015)

Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK
por: Halekotte, Jakob, et al.
Publicado: (2017)

Antimicrobial and Antifungal Activity of Rare Substituted 1,2,3-Thiaselenazoles and Corresponding Matched Pair 1,2,3-Dithiazoles
por: Laitinen, Tuomo, et al.
Publicado: (2020)

Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug Conjugates
por: Bahrami, Katayun, et al.
Publicado: (2022)

Antitumoral activity of allosteric inhibitors of protein kinase CK2
por: Moucadel, Virginie, et al.
Publicado: (2011)

The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design
por: Cozza, Giorgio
Publicado: (2017)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)

Synthesis and SAR of Tetracyclic Inhibitors of Protein Kinase CK2 Derived from Furocarbazole W16
por: Kröger, Lukas, et al.
Publicado: (2020)

Potent Inhibitor of Human Trypsins from the Aeruginosin Family of Natural Products
por: Ahmed, Muhammad N., et al.
Publicado: (2021)

Assessing the Inhibitory Potential of Kinase Inhibitors In Vitro: Major Pitfalls and Suggestions for Improving Comparability of Data Using CK1 Inhibitors as an Example
por: Roth, Aileen, et al.
Publicado: (2021)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021)

CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)

Malaria Protein Kinase CK2 (PfCK2) Shows Novel Mechanisms of Regulation
por: Graciotti, Michele, et al.
Publicado: (2014)

Protein Kinase CK-1 Inhibitors As New Potential Drugs for Amyotrophic Lateral Sclerosis
por: Salado, Irene G., et al.
Publicado: (2014)

Impact of protein kinase CK2 inhibitors on proliferation and differentiation of neural stem cells
por: Bender, Melanie, et al.
Publicado: (2017)

Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 Inhibitors
por: Martínez, Regina, et al.
Publicado: (2020)

The Multiple Personalities of the Regulatory Subunit of Protein Kinase CK2: CK2 Dependent and CK2 Independent Roles Reveal a Secret Identity for CK2β
por: Bibby, Ashley C., et al.
Publicado: (2005)

Protein Kinase CK2 in Cancer Energetics
por: Silva-Pavez, Eduardo, et al.
Publicado: (2020)

Machine Learning-Boosted Docking Enables the Efficient Structure-Based Virtual Screening of Giga-Scale Enumerated Chemical Libraries
por: Sivula, Toni, et al.
Publicado: (2023)

Whole grain intake associated molecule 5-aminovaleric acid betaine decreases β-oxidation of fatty acids in mouse cardiomyocytes
por: Kärkkäinen, Olli, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j30lj79ke62k379mclvlfmovs3